Back to search

Article

Precisely Correcting SMN Deficiency Pathways in Spinal Muscular Atrophy Using an Off-Amyloid Stabilizer

2024-07-11

Abstract excerpt

<title>Abstract</title> <p>While therapies like Spinraza, Zolgensma, and Evrysdi focus on increasing SMN1 protein levels to treat spinal muscular atrophy (SMA), their effectiveness is limited and highly dependent on early intervention. This indicates that merely augmenting SMN levels may not adequately reverse the permanent pathological effects stemming from SMN1 deficiency. Our research indicates that SMA is a p...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
21cbd671-14df-5d10-a1e4-f194409dd342
DOI
10.21203/rs.3.rs-4586057/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Precisely Correcting SMN Deficiency Pathways in Spinal Muscular Atrophy Using an Off-Amyloid StabilizerDOI 10.21203/rs.3.rs-4586057/v1
Select a neighboring publication to make it the new centre.